BAJAJHCARE vs HIKAL: Stock Comparison

Bajaj Healthcare Limited vs Hikal Limited

Live data: 22 July 2026, 3:07 PM IST • Source: NSE and company filings

Hikal Limited is the larger company by market capitalisation. Bajaj Healthcare Limited shows a higher ROE, lower leverage and a higher ROCE, while Hikal Limited shows a lower P/E, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Bajaj Healthcare Limited and Hikal Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, BAJAJHCARE is more favourable on 7 of 13 scored metrics and HIKAL on 6These counts are context-free and are not an overall rating.

Key Differences

Market Cap
HIKAL is the larger company
₹2,637 Cr vs ₹1,087 Cr
P/E Ratio
HIKAL has a lower P/E
-56.64x vs 64.24x
P/B Ratio
HIKAL has a lower P/B
2.31x vs 2.34x
EPS
BAJAJHCARE has higher earnings per share
₹7 vs ₹-3.95
Dividend Yield
HIKAL has a higher dividend yield
0.44% vs 0.26%
Revenue Growth (TTM YoY)
HIKAL has faster revenue growth
37.3% vs -0.9%
EPS Growth (TTM YoY)
HIKAL has faster EPS growth
68.3% vs 0%
Qtr Sales Growth
BAJAJHCARE has stronger quarterly sales growth
-0.91% vs -5.97%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricBAJAJHCAREHIKAL
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricBAJAJHCAREHIKAL
Live Price₹323₹213.16
Day Change-12.55%-5.15%
Volume14.07 L3.55 L
52-Week High₹537.95₹343.85
52-Week Low₹272.35₹146.25
Distance from 52W High-39.96%-38.01%

Valuation

MetricBAJAJHCAREHIKAL
Market Cap₹1,087 Cr₹2,637 Cr
P/E Ratio64.24x-56.64x
P/B Ratio2.34x2.31x
EPS₹7₹-3.95
Book Value₹167.01₹97.4
Dividend Yield0.26%0.44%

Growth

MetricBAJAJHCAREHIKAL
Revenue Growth (TTM YoY)-0.9%37.3%
EPS Growth (TTM YoY)0%68.3%
Qtr Sales Growth-0.91%-5.97%
Qtr Profit Growth19.2%22.5%

Profitability & Leverage

MetricBAJAJHCAREHIKAL
ROE9.4%2.95%
ROCE11.5%3.52%
Net Margin2.56%-2.88%
Operating Margin17.2%12.9%
Debt to Equity0.47x0.57x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricBAJAJHCAREHIKAL
Promoter Holding58.59% 0.3 pp68.85%
FII Holding2.19% 0.21 pp1.43% 0.87 pp
DII Holding1.92% 0.99 pp7.2% 0.15 pp
Public Holding37.3% 0.48 pp22.52% 0.73 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Bajaj Healthcare Limited and Hikal Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.